Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy

被引:6
作者
Cerro, Paulina A. [1 ]
Mascaraque, Marta [2 ,3 ]
Gallego-Rentero, Maria [2 ,3 ]
Almenara-Blasco, Manuel [1 ]
Nicolas-Morala, Jimena [2 ,3 ]
Luis Santiago, Juan [4 ]
Gonzalez, Salvador [5 ]
Gracia-Cazana, Tamara [1 ]
Juarranz, Angeles [2 ,3 ]
Gilaberte, Yolanda [1 ]
机构
[1] Miguel Servet Univ Hosp, Inst Invest Sanitaria IIS, Dept Dermatol, Zaragoza, Aragon, Spain
[2] Univ Autonoma Madrid, Dept Biol, Madrid, Spain
[3] Inst Ramon y Cajal Invest Sanitarias, Dept Experminetal Dermatol & Skin Biol, Madrid, Spain
[4] Hosp Gen Ciudad Real, Serv Dermatol, Ciudad Real, Spain
[5] Univ Alcala, Dept Med & Med Specialties, Madrid, Spain
关键词
tumor microenvironment; non-melanoma skin cancer; resistance; photodynamic therapy; cancer-asssociated fiboroblasts; immune cells; mast cell; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; CARCINOMA-ASSOCIATED FIBROBLASTS; PARACRINE TGF-BETA; COLORECTAL-CANCER; STROMAL CELLS; PROGRESSION; CHEMORESISTANCE; PROMOTE; METASTASIS;
D O I
10.3389/fonc.2022.970279
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-melanoma skin cancer has recently seen an increase in prevalence, and it is estimated that this grow will continue in the coming years. In this sense, the importance of therapy effectiveness has increased, especially photodynamic therapy. Photodynamic therapy has attracted much attention as a minimally invasive, selective and repeatable approach for skin cancer treatment and prevention. Although its high efficiency, this strategy has also faced problems related to tumor resistance, where the tumor microenvironment has gained a well-deserved role in recent years. Tumor microenvironment denotes a wide variety of elements, such as cancer-associated fibroblasts, immune cells, endothelial cells or the extracellular matrix, where their interaction and the secretion of a wide diversity of cytokines. Therefore, the need of designing new strategies targeting elements of the tumor microenvironment to overcome the observed resistance has become evident. To this end, in this review we focus on the role of cancer-associated fibroblasts and tumor-associated macrophages in the resistance to photodynamic therapy. We are also exploring new approaches consisting in the combination of new and old drugs targeting these cells with photodynamic therapy to enhance treatment outcomes of non-melanoma skin cancer.
引用
收藏
页数:14
相关论文
共 50 条
[41]   Surgery combined with photodynamic therapy versus surgery alone for the treatment of non-melanoma skin cancer and actinic keratosis: A retrospective cohort study [J].
Yang, Wanjun ;
Liu, Lihua ;
Yang, Wenfeng ;
Wang, Daiwen .
DERMATOLOGIC THERAPY, 2022, 35 (08)
[42]   Tumor microenvironment and cancer therapy resistance [J].
Sun, Yu .
CANCER LETTERS, 2016, 380 (01) :205-215
[43]   Non-melanoma skin cancer of the head and neck [J].
Roland, Nick ;
Memon, Aamir .
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2023, 84 (04)
[44]   Histopathological evaluation of non-melanoma skin cancer [J].
Ali Koyuncuer .
World Journal of Surgical Oncology, 12
[45]   Palliative Radiotherapy for Non-melanoma Skin Cancer [J].
Barnes, E. A. ;
Breen, D. ;
Culleton, S. ;
Zhang, L. ;
Kamra, J. ;
Tsao, M. ;
Balogh, J. .
CLINICAL ONCOLOGY, 2010, 22 (10) :844-849
[46]   Management of the Neck for Non-melanoma Skin Cancer [J].
Manojlovic-Kolarski M. ;
Yao C.M.K.L. ;
Chepeha D.B. .
Current Otorhinolaryngology Reports, 2018, 6 (4) :318-329
[47]   Histopathological evaluation of non-melanoma skin cancer [J].
Koyuncuer, Ali .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
[48]   Treatment of Non-melanoma Skin Cancer in the Elderly [J].
Zeitany A. ;
Adamson A. .
Current Geriatrics Reports, 2018, 7 (4) :216-221
[49]   Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives [J].
Zambrano-Roman, Marianela ;
Padilla-Gutierrez, Jorge R. ;
Valle, Yeminia ;
Munoz-Valle, Jose F. ;
Valdes-Alvarado, Emmanuel .
CANCERS, 2022, 14 (10)
[50]   Photodynamic Therapy: The Light Treatment for Cutaneous Non-Melanoma Malignancies [J].
Yu, Edward .
CURRENT CANCER THERAPY REVIEWS, 2016, 12 (02) :124-137